ZNF202
Basic information
Region (hg38): 11:123723914-123741675
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF202 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 1 | 2 |
Variants in ZNF202
This is a list of pathogenic ClinVar variants found in the ZNF202 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-123726079-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
11-123726119-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
11-123726148-C-A | not specified | Uncertain significance (May 31, 2022) | ||
11-123726171-C-A | not specified | Uncertain significance (Aug 08, 2022) | ||
11-123726244-C-A | not specified | Uncertain significance (Jul 12, 2023) | ||
11-123726248-G-T | not specified | Uncertain significance (Apr 08, 2024) | ||
11-123726266-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
11-123726283-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
11-123726292-C-T | not specified | Uncertain significance (May 27, 2022) | ||
11-123726320-A-T | not specified | Uncertain significance (Apr 04, 2024) | ||
11-123726486-G-A | Benign (Oct 24, 2018) | |||
11-123726574-A-T | not specified | Uncertain significance (May 26, 2024) | ||
11-123726610-T-G | not specified | Uncertain significance (Sep 23, 2023) | ||
11-123726637-C-T | not specified | Uncertain significance (Jun 29, 2022) | ||
11-123726869-C-G | not specified | Uncertain significance (Dec 17, 2021) | ||
11-123726967-T-A | not specified | Uncertain significance (Feb 07, 2023) | ||
11-123728142-C-A | not specified | Uncertain significance (Jan 30, 2024) | ||
11-123728210-C-T | not specified | Uncertain significance (Sep 01, 2021) | ||
11-123728235-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
11-123729162-G-T | not specified | Uncertain significance (Oct 26, 2022) | ||
11-123729200-C-T | not specified | Uncertain significance (Nov 02, 2023) | ||
11-123729656-C-T | not specified | Uncertain significance (Jan 21, 2022) | ||
11-123729668-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
11-123729714-C-T | not specified | Uncertain significance (Apr 21, 2022) | ||
11-123729722-G-A | not specified | Likely benign (Jan 18, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF202 | protein_coding | protein_coding | ENST00000336139 | 6 | 17499 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.526 | 0.474 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.69 | 277 | 369 | 0.752 | 0.0000211 | 4240 |
Missense in Polyphen | 94 | 159.17 | 0.59057 | 1859 | ||
Synonymous | -0.326 | 147 | 142 | 1.03 | 0.00000844 | 1245 |
Loss of Function | 3.88 | 6 | 28.3 | 0.212 | 0.00000147 | 334 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor that binds to elements found predominantly in genes that participate in lipid metabolism. Among its targets are structural components of lipoprotein particles (apolipoproteins AIV, CIII, and E), enzymes involved in lipid processing (lipoprotein lipase, lecithin cholesteryl ester transferase), transporters involved in lipid homeostasis (ABCA1, ABCG1), and several genes involved in processes related to energy metabolism and vascular disease.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.338
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 39.11
Haploinsufficiency Scores
- pHI
- 0.147
- hipred
- N
- hipred_score
- 0.359
- ghis
- 0.572
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.639
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zfp202
- Phenotype
- growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;lipid metabolic process
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;metal ion binding